MAXCYTE, INC. Balance Sheet
MXCT|5 years of annual SEC 10-K data (FY2021-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 5 fiscal years. All figures from audited SEC 10-K filings.
MAXCYTE, INC. had $203M in total assets and $171M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.96 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | $20.1M | $27.9M | $46.5M | $11.1M | $47.8M |
| Accounts Receivable | $3.5M | $4.7M | $5.8M | $11.2M | $6.9M |
| Inventory | $7.5M | $8.9M | $12.2M | $8.6M | $5.2M |
| Current Assets | $118.4M | $171.7M | $190.2M | $252.3M | $270.4M |
| PP&E (Net) | $17.5M | $19.7M | $23.5M | $23.7M | $7.7M |
| Total Assets | $202.5M | $239.5M | $268.3M | $286.7M | $284.1M |
| Current Liabilities | $14.3M | $15.8M | $17.9M | $15.4M | $15.6M |
| Shareholders' Equity | $171.5M | $232.2M | $254.0M | $254.0M | $262.9M |